Physician profile
Emma Reeve
NPI 1801374913
$14,724.16
in general payments reported to CMS, 2019-2025
50 companies · $4,010 in 2025
The $4,010 reported for 2025 was more than what 97% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,037 · 2022: $2,614 · 2023: $2,828 · 2024: $3,236 · 2025: $4,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,949 · Travel and Lodging: $1,015 · Gift: $59.40 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,948.98 |
| Travel and Lodging | $1,014.96 |
| Gift | $59.40 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,225.60 | 2021-2025 | Minimed 780g, Intellis Adaptivestim, Minimed 770g |
| Novo Nordisk INC | $1,478.76 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $1,455.91 | 2021-2025 | Korlym |
| Lilly USA, LLC | $1,444.19 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Abbott Laboratories | $949.47 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $698.93 | 2021-2025 | Evenity, Prolia, Tepezza |
| Sanofi-Aventis U.S. LLC | $610.23 | 2021-2025 | |
| Abbvie INC. | $548.61 | 2021-2025 | |
| Dexcom, INC. | $484.41 | 2021-2025 | Dexcom G6 Transmitter |
| Mannkind Corporation | $383.20 | 2021-2025 | Afrezza |
| Radius Health, INC. | $355.28 | 2021-2025 | Tymlos |
| Beta Bionics, INC. | $316.74 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Bayer Healthcare Pharmaceuticals INC. | $272.98 | 2021-2024 | |
| Averitas Pharma INC. | $263.92 | 2024-2025 | Qutenza |
| Recordati_rare_diseases_inc. | $260.56 | 2024-2025 | Isturisa, Signifor Lar |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.82 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $243.83 | 2021-2025 | Farxiga |
| Alexion Pharmaceuticals, INC. | $222.23 | 2021-2025 | Strensiq |
| Tandem Diabetes Care, INC. | $214.86 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $213.73 | 2021-2025 | Omnipod |
| Currax Pharmaceuticals LLC | $199.87 | 2022-2025 | Contrave, Nexletol, Nexlizet |
| Amneal Pharmaceuticals LLC | $187.75 | 2021-2025 | Unithroid |
| Sequel Med Tech, LLC | $176.79 | 2025 | Twiist |
| Xeris Pharmaceuticals, INC. | $176.70 | 2021-2024 | Recorlev, Gvoke Hypopen |
| Intuity Medical INC | $139.03 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Zealand Pharma US, INC. | $118.40 | 2021 | |
| Cequr Corporation | $87.33 | 2023-2025 | Cequr Simplicity |
| Ascensia Diabetes Care US INC. | $77.03 | 2022-2024 | |
| Ascendis Pharma Endocrinology INC | $73.54 | 2023-2024 | |
| Amphastar Pharmaceuticals, INC. | $66.75 | 2024-2025 | |
| Amryt Pharma Holdings LTD | $56.91 | 2021-2023 | Mycapssa, Myalept |
| Verity Pharmaceuticals INC. | $56.00 | 2024 | Tlando |
| Neurocrine Biosciences, INC. | $39.04 | 2025 | |
| Horizon Therapeutics Plc | $38.96 | 2021-2023 | Tepezza |
| Alvogen INC | $36.00 | 2023-2024 | Teriparatide |
| Tolmar, INC. | $33.30 | 2024-2025 | Jatenzo |
| Ultragenyx Pharmaceutical INC. | $27.74 | 2023 | |
| Glaxosmithkline, LLC. | $27.27 | 2025 | Shingrix, Arexvy |
| Inspire Medical Systems, INC. | $25.10 | 2025 | Inspire |
| Vivus LLC | $23.56 | 2024 | Qsymia |
| Novartis Pharmaceuticals Corporation | $20.59 | 2022 | |
| Globus Medical, INC. | $18.87 | 2025 | Senza |
| Madrigal Pharmaceuticals | $17.82 | 2025 | Rezdiffra |
| Evoke Pharma, INC. | $16.65 | 2025 | |
| Vistapharm, INC. | $16.14 | 2021 | |
| Antares Pharma, INC. | $15.31 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $14.34 | 2021 | |
| Acella Pharmaceuticals, LLC | $14.25 | 2024 | NP Thyroid 60 |
| Kowa Pharmaceuticals America, INC. | $13.89 | 2021 | |
| Grt US Holding, INC. | $11.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Reeve listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.